Change over period: —
NSE · ZYDUSWELL
ZYDUS WELL
-24.2% from the 52-week high · +22.2% above the low
Zydus Wellness Ltd. engages in the business of development, production, marketing, and distribution of health and wellness products. The company is headquartered in Ahmedabad, Gujarat and currently employs 748 full-time employees. The firm operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The Company’s product portfolio includes brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite. Glucon-D is a glucose powder, which is available in various flavors variants with Vitamin D and Vitamin C. Complan is a health food drink, scientifically designed for growing school children and contains nutrients along with milk protein. Sugar Free is a low-calorie sweetener, which is a replacement of sugar for the calorie-conscious, weight watchers and diabetics. Everyuth offers a range of skincare products under the brand name of Everyuth Naturals. Nycil prickly heat and cooling powder brand and has also expanded portfolio into hand sanitizer category.
The short version. ZYDUS WELL reported revenue of ₹1,127 crore for Sep 2026, up 73.4% from a year earlier. Net profit was ₹5 crore. Return on equity was 3.4% in Mar 2026. Promoter holding was 69.63% in Sep 2026, up 0.01 points over 8 quarters.
1 · The price
How has the stock traded?
ZYDUS WELL trades 24.2% below its 52-week high and 22.2% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹1,127 cr.
8.6 pts higher than a year earlier.
Revenue compounded at 20.6% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1127 | 1437 | 1485 | 965 | 650 | 861 | 913 | 462 |
| Net profit | 5 | 119 | 162 | -40 | -53 | 128 | 172 | 6 |
| Net margin % | 0.5 | 8.3 | 10.9 | -4.1 | -8.1 | 14.9 | 18.8 | 1.4 |
| EPS (₹) | 0.16 | 3.74 | 5.09 | -1.25 | -1.66 | 4.02 | 5.4 | 0.2 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3961 | 2709 | 2328 | 2255 | 2009 | 1867 | 1767 | 843 |
| Net profit | 197 | 347 | 267 | 310 | 308 | 119 | 142 | 169 |
| Net margin % | 5.0 | 12.8 | 11.5 | 13.8 | 15.3 | 6.4 | 8.0 | 20.1 |
| EPS (₹) | 6.2 | 10.9 | 8.39 | 9.76 | 9.68 | 3.73 | 4.92 | 5.87 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 3.4% in Mar 2026; debt to equity is 0.55.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 3.4 | 6.1 | 5.0 | 6.1 |
| Return on capital % | 3.4 | 6.5 | 5.3 | 6.0 |
| EBITDA margin % | 12.0 | 14.7 | 13.2 | 14.7 |
| Net margin % | 5.0 | 12.7 | 11.4 | 13.7 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 20.6% | 16.2% |
| Profit CAGR | -14.0% | 10.7% |
4 · The owners
Who holds it, and are they adding?
Up 0.01 pts over 8 quarters.
Up 0.19 pts over 8 quarters.
Down 0.73 pts over 8 quarters.
+19 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.62 | 69.63 | 69.63 | 69.63 | 69.63 | 69.63 | 69.63 | 69.63 | +0.01 |
| FII | 3.37 | 3.29 | 3.25 | 3.43 | 3.27 | 3.18 | 3.32 | 3.56 | +0.19 |
| DII | 20.12 | 19.76 | 19.28 | 18.76 | 18.58 | 18.87 | 19.14 | 19.39 | -0.73 |
| Public | 6.89 | 7.31 | 7.83 | 8.18 | 8.52 | 8.31 | 7.91 | 7.41 | +0.52 |
Mutual fund holdings · Oct 2026
71 schemes hold this stock
52 the month before.
- quant Manufacturing Fund7.37% of NAV
- quant Healthcare Fund4.5% of NAV
- Bajaj Finserv ELSS - Tax Saver Fund4.27% of NAV
- Bajaj Finserv Consumption Fund3.8% of NAV
- quant Business Cycle Fund3.04% of NAV
- Bajaj Finserv Small Cap Fund2.69% of NAV
- UNION CONSUMPTION FUND2.55% of NAV
- Nippon India Consumption Fund2.29% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for ZYDUS WELL are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Food Products stocks
Quick answers
Common questions about ZYDUS WELL
What is the ZYDUS WELL share price?
ZYDUS WELL (ZYDUSWELL) last closed at ₹455.85, down 0.16% on the day. Its 52-week range is ₹373.50 to ₹602.50.
What is the market cap of ZYDUS WELL?
ZYDUS WELL has a market capitalisation of about ₹14,527 crore. Its price-to-earnings ratio is 60.4.
How are ZYDUS WELL's latest results?
ZYDUS WELL reported revenue of ₹1,127 crore for Sep 2026, up 73.4% from a year earlier. Net profit was ₹5 crore. Return on equity was 3.4% in Mar 2026. Promoter holding was 69.63% in Sep 2026, up 0.01 points over 8 quarters.
Who owns ZYDUS WELL?
As of Sep 2026, shareholding was: Promoter 69.63%, FII 3.56%, DII 19.39%, Public 7.41%.
How many mutual funds hold ZYDUS WELL?
71 mutual fund schemes held ZYDUS WELL in October 2026. That compares with 52 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 18 Sep 2025 · Stock Split From Rs.10/- to Rs.2/-
- 11 Jul 2025 · Final Dividend - Rs. 6
- 19 Jul 2024 · Final Dividend - Rs. 5
- 21 Jul 2023 · Final Dividend - Rs. 5
- 14 Jul 2022 · Final Dividend - Rs. 5
- 14 Jul 2021 · Final Dividend - Rs. 5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.